Ultragenyx Pharmaceutical (RARE) Finished Goods (2017 - 2026)
Ultragenyx Pharmaceutical (RARE) reported Finished Goods of $27 million for Q2 2026, up 1.0% from $26.74 million a year earlier and up 22.7% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Finished Goods (2017 - 2026) Analysis & Trends
At the end of FY2025, Ultragenyx Pharmaceutical posted Finished Goods of $25 million, up 8.7% from FY2024.
- Finished Goods has increased for four consecutive years, with a five-year compound annual growth rate of 33.6% (FY2020 to FY2025).
- By year, Finished Goods came in at $23 million in FY2024 (+52.2%), $15.11 million in FY2023 (+62.8%), $9.28 million in FY2022 (+62.0%) and $5.73 million in FY2021 (-2.3%).
- The Q2 2026 figure ranks as the highest quarterly Finished Goods in data going back to Q4 2017.
- Year over year, Finished Goods gained in six of the last eight quarters, with growth averaging 37.0%.
- The high point for year-over-year Finished Goods in five years was Q3 2023 (growth of 108.0%); the low point was Q2 2022 (a decline of 13.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $22 million (Q1 2026), $25 million (Q4 2025) and $23.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.62 Bn | -186.47 Mn | 180.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.00 Mn |
| Mar 31, 2026 | 22.00 Mn |
| Dec 31, 2025 | 25.00 Mn |
| Sep 30, 2025 | 23.01 Mn |
| Jun 30, 2025 | 26.74 Mn |
| Mar 31, 2025 | 23.12 Mn |
| Dec 31, 2024 | 23.00 Mn |
| Sep 30, 2024 | 23.05 Mn |
| Jun 30, 2024 | 14.89 Mn |
| Mar 31, 2024 | 13.09 Mn |
| Dec 31, 2023 | 15.11 Mn |
| Sep 30, 2023 | 12.63 Mn |
| Jun 30, 2023 | 9.72 Mn |
| Mar 31, 2023 | 11.53 Mn |
| Dec 31, 2022 | 9.28 Mn |
| Sep 30, 2022 | 6.07 Mn |
| Jun 30, 2022 | 4.89 Mn |
| Mar 31, 2022 | 5.82 Mn |
| Dec 31, 2021 | 5.73 Mn |
| Sep 30, 2021 | 5.65 Mn |
API Access
Ultragenyx Pharmaceutical Finished Goods API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=finished-goods&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "finished-goods", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=finished-goods&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();